Injector Lifecycle

Bayer MEDRAD Injector End of Life Dates and What They Mean

Bayer is retiring its legacy contrast injector platforms and pointing customers toward its current systems, the MEDRAD Stellant FLEX and Centargo for CT and the MEDRAD MRXperion for MR. Those are capable machines and a sensible choice when new equipment fits the budget. Worth knowing as you plan: each of them runs its own consumable line, so the kits you stock today do not move with you. A qualified refurbished injector on the platform you already run is also a legitimate option, and your syringes, protocols and training all stay exactly as they are. If you operate a Stellant or a Spectris Solaris EP, an end-of-life date has already been published for your system. Here is what Bayer has announced, what it withdraws, and what your options actually are.

Published End of Life Dates

Platform	End of life	Status
MEDRAD Stellant CT Injection Systems - Classic models, Dual and Single, and with Certegra Workstation	12/31/2028	Announced
MEDRAD Spectris Solaris EP MR Injection System and Solaris EP Mobile	12/31/2028	Announced
MEDRAD Mark V ProVis Injection System	12/31/2025	Passed
MEDRAD Spectris MR Injection System	12/31/2024	Passed
MEDRAD Spectris Solaris MR, Vistron CT, EnVision CT, MCT and MCT Plus, Mark V and Mark V Plus, Mark IV, Mark ProVis, Certegra Workstation 1.0, XDS Extravasation Detector, Intego PET 100	Already discontinued, end-of-life letters published by Bayer

Source: Bayer Radiology, Product Lifecycle Announcements. Confirm against Bayer's current page before making a purchasing decision.

Compiled by FDM Enterprises | 615-479-5572 | fdmenterprises.com

What an End of Life Date Withdraws

Bayer states that after the end-of-life date it will no longer offer service, including preventive maintenance, equipment calibration, replacement parts and technical support, or consumables for that installed base. In practice that is five separate problems arriving on the same day:

No preventive maintenance

Your annual PM has to come from somewhere else, and accreditation and risk-management programs still expect documented maintenance on injection equipment.

No calibration

Flow rate and volume verification still need performing and documenting.

No replacement parts

Component failures move to third-party stock and repair rather than replacement.

No technical support

No factory line when the head faults mid-shift.

No consumables

The one departments underestimate. Bayer has already discontinued the SQK 65VS, CTP-200-FLS, 150-FT-Q and 200-FT-Q kits.

End of life

Your Three Options

Replace on Bayer's schedule

Bayer’s path

Centargo for CT, MRXperion for MR.

Legitimate, and a capital request on someone else’s timeline
Each platform runs its own consumable line, so the kits you stock today do not carry over

We Buy the Unit You Retire

Keep the system running

Lowest cost

Independent service and compatible consumables.

Preventive maintenance, calibration verification and repair
FDA-cleared compatible kits, including ones Bayer has discontinued
Lowest cost by a wide margin when the hardware is sound, which on most of these platforms it is

See the Uptime Program

Bridge to a planned replacement

On your timeline

Keep it serviced and supplied while capital planning runs its course.

Nothing forces a rushed purchase in a budget year you did not plan for
A refurbished unit on your current platform keeps your syringes, protocols and training as they are

Talk It Through

We are not going to tell you to replace working equipment. If a unit is beyond economical repair we will say so, and we also buy used imaging equipment and sell refurbished injectors when you retire one.

Running One of These?

We service Stellant, Spectris and Spectris Solaris, and we supply the consumables for them, including platforms Bayer has already discontinued. Call 615-479-5572. Syringes and Tubing.

Injector Uptime Program

Frequently Asked Questions

Independent service organizations do. We service the Stellant, Spectris and Spectris Solaris across the central and southeastern US, including platforms Bayer has already retired, and we supply the consumables for them. See the Injector Uptime Program.

Bayer has published 12/31/2028 for the Stellant CT Injection Systems, covering the Classic models, the Dual and Single models, and the version with the Certegra Workstation.

Yes, 12/31/2028. The earlier non-EP Spectris Solaris and the original Spectris are already discontinued.

End of life is a support decision, not a safety recall. What matters is that preventive maintenance and calibration verification continue to be performed and documented by a qualified provider.

Not from Bayer for that platform. FDA-cleared compatible kits are manufactured for all of these systems and we supply them. See the syringe cross reference.

No. Those are Bayer's upgrade paths, not a requirement. Independent service and compatible consumables are a legitimate alternative for a system that still performs.

It depends on the unit and how it has been maintained. A preventive maintenance visit and an honest inspection will tell you far more than a date on a letter.

SQK 65VS, CTP-200-FLS, 150-FT-Q and 200-FT-Q.

We would rather you checked this against the source than took our word for it. These are Bayer's published documents.

No obligation

Tell Us What You Run

Your injector model and roughly how many contrast studies you run a month. That is enough for a straight answer about what it takes to keep it running.